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SUMMARY. The avian coronavirus infectious bronchitis virus (AvCoV-IBV) is recognized as an important global pathogen
because new variants are a continuous threat to the poultry industry worldwide. This study investigates the genetic origin and
diversity of AvCoV-IBV by analysis of the S1 sequence derived from 49 broiler flocks and 14 layer flocks in different regions of
Turkey. AvCoV-IBV RNA was detected in 41 (83.6%) broiler flocks and nine (64.2%) of the layer flocks by TaqMan real-time
RT-PCR. In addition, AvCoV-IBV RNA was detected in the tracheas 27/30 (90%), lungs 31/49 (62.2%), caecal tonsils 7/22
(31.8%), and kidneys 4/49 (8.1%) of broiler flocks examined. Pathologic lesions, hemorrhages, and mononuclear infiltrations were
predominantly observed in tracheas and to a lesser extent in the lungs and a few in kidneys. A phylogenetic tree based on partial S1
sequences of the detected AvCoV-IBVs (including isolates) revealed that 1) viruses detected in five broiler flocks were similar to the
IBV vaccines Ma5, H120, M41; 2) viruses detected in 24 broiler flocks were similar to those previously reported from Turkey and
to Israel variant-2 strains; 3) viruses detected in seven layer flocks were different from those found in any of the broiler flocks but
similar to viruses previously reported from Iran, India, and China (similar to Israel variant-1 and 4/91 serotypes); and 4) that the
AVCoV-IBV, Israeli variant-2 strain, found to be circulating in Turkey appears to be undergoing molecular evolution. In
conclusion, genetically different AvCoV-IBV strains, including vaccine-like strains, based on their partial S1 sequence, are
circulating in broiler and layer chicken flocks in Turkey and the Israeli variant-2 strain is undergoing evolution.
RESUMEN. Ana´lisis filogene´tico y variacio´n del gene S1 de virus de la bronquitis infecciosa detectados en pollos y gallinas de
postura en Turquı´a.
El coronavirus aviar conocido como el virus de la bronquitis infecciosa aviar (AvCoV-IBV), es reconocido como un pato´geno global
importante debido a que las nuevas variantes son una amenaza continua para la industria avı´cola en todo el mundo. En este estudio se
investigo´ el origen gene´tico y la diversidad de los virus de bronquitis de bronquitis mediante el ana´lisis de la secuencia del gene S1 de
virus derivados de 49 lotes de pollos y de14 lotes de ponedoras en diferentes regiones de Turquı´a. Se detecto´ ARN del virus de la
bronquitis infecciosa en 41 (83.6%) lotes de pollos y en nueve (64.2%) de los lotes de ponedoras por un me´todo de transcripcio´n
reversa y PCR en tiempo con sondas TaqMan. Adema´s, se detecto´ ARN de virus de la bronquitis infecciosa en las tra´queas 27/30
(90%), los pulmones 31/49 (62.2%), las tonsilas cecales 7/22 (31.8%), y rin˜ones 4/49 (8.1%) de las parvadas de pollo de engorde
examinadas. Se observaron lesiones patolo´gicas, hemorragias, e infiltraciones mononucleares principalmente en las tra´queas, en menor
medida en los pulmones y en algunos rin˜ones. Un a´rbol filogene´tico basado en las secuencias parciales del gene S1 de los virus de la
bronquitis detectados (incluyendo aislamientos) revelo´ que 1) los virus detectados en cinco lotes de pollos fueron similares a las vacunas
Ma5, H120, M41; 2) los virus detectados en 24 lotes de pollos fueron similares a los virus previamente reportados en Turquı´a y a las
cepas variantes 2 de Israel; 3) los virus detectados en siete parvadas de gallinas de postura fueron diferentes de los virus que se detectaron
en todas las parvadas de pollos de engorde, pero similares a los virus que se habı´an reportado en Ira´n, India y China (similares a la
variante 1 de Israel y a los serotipos 4/91); y 4) que la cepa variante 2 de Israel que se encontro´ circulando en Turquı´a parec´ıa que estaba
experimentando evolucio´n molecular. En conclusio´n, cepas del virus de la bronquitis infecciosa que fueron gene´ticamente diferentes,
con base en la secuencia parcial del gene S1 y que incluyeron cepas similares a vacunas, se encontraron circulando en pollos de engorde
y en gallinas de postura en Turquı´a y la cepa variante 2 de Israel se encontro´ experimentando evolucio´n.
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Abbreviations: AvCoV-IBV ¼ avian coronavirus–infectious bronchitis virus; cDNA ¼ complementary DNA; IB ¼ infectious
bronchitis; IBV ¼ infectious bronchitis virus; MEM ¼ minimal essential medium; RT-PCR ¼ reverse transcriptase–polymerase
chain reaction; S1 ¼ Spike-1; SPF ¼ specific-pathogen-free
Infectious bronchitis virus (IBV) is an important pathogen of
chickens, threatening the poultry industry worldwide. It is the causal
agent of infectious bronchitis (IB), an acute and highly contagious
disease. Vaccines are available, but genetic variation and the lack ofHCorrepsonding author. E-mail: hyilmaz@istanbul.edu.tr
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cross-protection between different viral genotypes make the control
of infections difficult (6,7,12,22). Therefore it is important to
genetically characterize circulating strains of IBV to guide national
or regional strategies for combating IB by designing appropriate
diagnostics and vaccination regimes.
Avian coronavirus–infectious bronchitis virus (AvCoV-IBV) is an
enveloped, single-stranded RNA virus, belonging to the genus
Gammacoronavirus within the family of Coronaviridae and the order
Nidovirales. It has a 27 to 28 kb genome encoding four structural
proteins, spike (S), membrane (M), envelope (E), and nucleocapsid
(N) (6). Genetic differences affecting antigenicity and immunoge-
nicity are mainly restricted to the S protein. This is composed of two
subunits Spike-1 (S1) and -2, of which S1 is more variable. Genetic
variation, caused by mutations in the IBV S1 sequence, is
responsible for the worldwide diversity of IBV isolates (9,16,21,27).
The 793/B, Massachusetts, QX, and IT-02, serotypes have been
frequently reported (28) as circulating in Europe. However, different
strains of IBV have been circulating in the Middle East. For
example, IBV variants like Q1 (CK/CH/LDL97I/97)
(1,11,14,17,20,26,27), IBV variant-1 (793/B, IS/222/96, IS/251/
96, and IS/64714/96), IBV variant-2 (IS/223/96, IS/572/98, IS/
585/98, and IS/589/98), Egypt/Beni-Seuf/01, Sul/01/09, D274,
and IS/885/00 as well as vaccine strains derived from Massachusetts
and 4/91, (8,18,19,24,25) have been detected.
In Turkey, vaccine strains like Ma5, H120, 4/91 and Israeli
variant-2 have been detected (15). IBV vaccines containing Ma5, 4/
91, H120, Israel variant-2, and a combination of H120-D274
strains were used in broilers and H120, M41, and 4/91 in layers to
control virulent IB strains in Turkey. Despite the presence and
application of IBV vaccines in poultry, the emergence of new
AvCoV-IBV variants can threaten poultry health and production all
over the world. Therefore it is important to genetically characterize
circulating strains of AvCoV-IBV. This study was carried to
investigate S1 gene variation and pathologic lesions caused by
AvCoV-IBV in Turkey.
MATERIALS AND METHODS
Study population. Forty-nine commercial broiler and 14 layer flocks
were selected from four geographic regions of Turkey, (Marmara,
western Black Sea, the Mediterranean, and Inner Anatolia), between
January 2013 and June 2015. Flocks were selected by veterinarians using
the following criteria: flocks showing clinical signs of respiratory disease
and flocks from the same vicinity that did not show clinical signs of
respiratory disease. Flocks had been previously vaccinated against IBV
except two flocks without vaccination. IBV vaccines Ma5, 4/91, H120,
or Israel variant-2 were used in broilers, and 4/91 in layers analyzed in
this study (Table 1).
Sample collection. Layers: Four or five chickens either with or
without respiratory signs were selected from each layer flock and tracheal
swabs taken from these chickens. Broilers: Five 20-to-35-day-old birds
either with or without clinical signs of respiratory disease were selected.
The clinical signs were recorded, and they were then humanely
sacrificed, autopsied, and pathologic findings recorded. Tissue samples
from trachea, lung, kidneys, proventriculus, and intestine including
caecal tonsils were taken for virologic and histologic analysis. Samples
for histologic examination were fixed in 10% neutral buffered formalin
embedded in paraffin blocks and 4–5 lm sections cut, stained with
hematoxylin and eosin, and examined by light microscopy.
RNA extraction and reverse transcription. Total RNA was
extracted from tissues and allantoic fluid of inoculated eggs using
RNeasy and QIAamp Viral RNA mini kits, respectively, as described by
the manufacturer (Qiagen, Turkey). The amount of RNA, in 50 ll of
extracted sample, was determined using a NanoDrop spectrophotometer
(NanoDrop 1000c, Thermo Scientific, Waltham, MA). Reverse
transcription and generation of complementary DNA (cDNA) was
performed in two steps as described previously (31).
Detection of AvCoV-IBV by TaqMan real-time RT-PCR assay.
The TaqMan real-time RT-PCR used in this study was a modification
of the method described previously (4). The primers and probe specific
for IBV are given in Table 2. A standardized TaqMan real-time RT-
PCR reaction consisted of a total volume of 25 ll reaction mixture
containing of 12.5 ll GoTaqt Colorless Master Mix (Promega), 1 ll
IBV5-GU391 primer (5 pMol/ll), 1 ll IBV5-GL533 primer (5pMol/
ll), 0.2 ll IBV5-G probe (5pMol/ll), 5.3 ll nuclease-free water, and 5
ll cDNA. The mixture was placed in a thermal cycler (Biorad, Chromo-
4) and the polymerase activated, by incubation at 95 C for 2 min.
Cycling conditions were 94 C for 1 s and 60 C for 60 s over 40 cycles.
Negative controls included DNA extracted from samples that were
negative for AvCoV-IBV and nuclease-free water in place of template. A
positive control consisted of RNA from the trachea of a chicken
previously infected with IBV. The chicken GPADH (glyceraldehyde-3-
phosphate dehydrogenase) gene was used as an internal control for the
presence of RNA.
Virus isolation. Tissue samples (trachea, lung, or kidney) and
tracheal swabs that were positive for AvCoV-IBV, by TaqMan real-time
RT-PCR with a CT value of ,25 were subjected to virus isolation using
the conventional method of inoculating embryonated eggs. Briefly, 5 g
of lung, trachea, or kidney samples were homogenized in Glasgow
minimal essential medium (Biochrom, Turkey) containing 5%
antibiotic–antimycotic solution, filtered using a 0.22 lm Millipore
filter and the filtrates used to inoculate the chorioallantoic cavity of
groups of four 9- or 10-day-old specific-pathogen-free (SPF) embryo-
nated hens’ eggs (Veterinary Control Institute, Bornova, Izmir, Turkey).
Eggs were observed every other day, over 7 days, for the presence of
embryo death, vascularization and dwarfism. After 7 days RNA was
isolated from the allantoic fluid and analyzed by TaqMan real-time RT-
PCR for the presence of AvCoV-IBV RNA as described above. If
samples were negative on the first passage, second and third passages
were performed.
Partial S1 gene sequencing. The cDNA of IBV generated from
samples found positive by TaqMan real-time RT-PCR were subjected to
sequencing by using the primers given in Table 2. The IBV S1
sequences, generated from 29 samples derived from broiler flocks
positive for AvCoV-IBV and 7 samples derived from layer flocks
positive for AvCoV-IBV, were partially sequenced. The partial S1
sequences consisted of (1) a 393 bp PCR product from nucleotide
positions 705 to 1097 in the IBV S1 sequence produced by nested PCR
as described previously (29) and (2) a 462 bp PCR product from
nucleotide positions 1082 to 1545 in the IBV S1 sequence. To amplify
462 bp region of S1 gene, a standardized in house RT-PCR reaction
consisted of a total volume of 25 ll reaction mixture containing 0.5 ll
(1 lM) of forward (IBV FOR3) and reverse primers (IBV REV3), 12,5
ll GoTaqt Colorless Master Mix (Promega), 6.5 ll nuclease-free water,
and 5 ll of cDNA. The mixture was placed in a thermal cycler (Biorad,
Chromo-4), and the polymerase was then activated by incubation at 94
C for 15 min. Cycling conditions were 94 C for 30 sec, 50 C for 1 min,
and 68 C for 1 min for 40 cycles. Nuclease-free water was used as
negative control in place of template.
Phylogenetic analyses. The reference sequence set for IBV
classification obtained from Valastro and others (30) was used to
reconstruct the topology of the S1 sequences generated in this study.
The phylogenetic tree was inferred using the ML method available in
PhyML 3.0 (10) incorporating a GTR model of nucleotide substitution
with a gamma distribution of among-site rate variation (with four rate
categories, C4) and a SPR branch-swapping search procedure. Prior to
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phylogenetic analysis, all hypervariable and potentially poorly aligned
regions were removed using the Gblocks program (http://molevol.
cmima.csic.es/castresana/Gblocks.html) (5) as previously described by
Valastro and others (30). Nodal supports in the PhyML analysis were
assessed using Shimodaira-Hasegawa–like branch supports (10). The
GenBank accession numbers of some positive samples detected in this
study are KT021472, KT021473, KT021474, KT021475, KT021476,
KT021477, KT021478, and KT021479.
Table 2. Primers and probes used in the study.
Primers Sequences 50-30
Product
size (bp)
Target
region Location Reference
IBV5-GU391 GCTTTTGAGCCT AGCGTT 142 50-UTR 391–408A Callison et al. 2006 (4)
IBV5-GL533 GCCA TGTTGTCACTGTCT A TTG 533–512
IBV5-G probe FAM-CACCACCAGAACCTGTCACCTC-BHQ 494–473
SX1 CACCTAGAGGTTTGT/CTA/T GCAT 393 S1 gene 677–698B Worthington et al. 2008 (29)
SX2 TCCACCTCTATAAACACC C/T TT 1148–1168
SX3 TAATACTGG C/T AATTTTTCAGA 705–725
SX4 AATACAGATTGCTTACAACCACC 1075–1097
IBV-FOR3 GTAAGCAATCTGTTTTTAGT 462 S1 gene 1082–1101C In house
IBV-REV3 CTAAAAGTAAGAATGCCAAC 1525–1545
AGenBank accession number AY851295.
BGenBank accession number Z83979.
CGenBank accession number KJ524614.
Table 1. Results analyzed in the study.A
Flock no.
(sequences derived) Vaccination CT value
Phylogenetic
tree results
Virus
isolation
Histopathologic lesions
K L T
Broilers
8 H120 22.22 Var-2 NI No þ þ
10 H120 29.18 Var-2 ND No þ þ
16 H120 23.49 Var-2 þ þþ þ þþ
18 H120 34.14 Var-2 ND þþ þ þþ
20 H120 23.42 Var-2 NI þþ þ þ
24 H120 33.64 Var-2 ND þþ þþ þ
22 H120 23.42 H120 NI þþ þþ þþ
23 H120 24.74 H120 NI þþ þþ þ
37 Var-2 24.46 Var-2 þ þ þþ ND
39 Var-2 22.81 Var-2 NI þ þþ ND
19 Var-2 30.89 Var-2 ND þ þþ þþ
2 Var-2 23.54 Var-2 þ þ þþ þþ
36 Var-2 31.66 H120 ND þ þ ND
38 Var-2 23.68 H120 NI þþ þþ ND
3 Ma5 24.99 Var-2 þ þþ þþ þþ
7 Ma5 20.59 Var-2 NI þþ þþ No
9 Ma5 19.6 Var-2 þ No þ þ
33 Ma5 24.34 Var-2 NI þ þþ ND
35 Ma5 34.66 Var-2 ND þ þþ ND
41 Ma5 34.86 Var-2 ND þ þ ND
44 Ma5 21.63 Var-2 NI þ þþ ND
47 Ma5 30.75 Var-2 ND ND ND ND
48 Ma5 22.81 Var-2 NI ND ND ND
49 Ma5 24.88 Var-2 NI þþ þþ ND
6 Ma5 32.97 H120 ND þþ þ þþ
14 Var-1 33.48 Var-2 ND þ þþ þþ
15 Apr-91 35.13 Var-2 ND þþ þ þ
28 Nonvaccinated 18.34 Var-2 þ þþþ þ þ
29 Nonvaccinated 25.38 Var-2 NI þþþ þþþ þ
Layers
1 Apr-91 20.04 Apr-91 NI
2 Apr-91 20.04 Apr-91 NI
3 Apr-91 34.71 Apr-91 ND
4 Apr-91 32.7 Apr-91 ND
5 Apr-91 20.3 Apr-91 þ
8 Apr-91 35.4 Apr-91 ND
14 Apr-91 30.1 Apr-91 ND
AK ¼ kidney; L ¼ lung; NI ¼ no isolate; ND ¼ not done; T ¼ trachea; þ¼ slight lesions; þþ¼mild lesions; þþþ¼ severe lesions.
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RESULTS
Clinical, necropsy, and histopathologic findings. Mortality rates
in clinically affected broiler flocks ranged from 4% to 9%. The
clinical signs observed in these flocks (Table 1: Flock 2, Flock 23,
Flock 24, Flock 28 nonvaccinated, Flock 29 nonvaccinated) ranged
from depression, ruffled feathers, poor growth, nasal discharge, rales,
and diarrhea. In contrast, only respiratory signs were observed in two
layer flocks.
At necropsy, the common lesions observed included congestion
and petechial hemorrhages in the trachea and additionally edema,
airsacculitis, and serous or seropurulent exudate in the lungs.
Congestion, hemorrhages, and erosions were observed in the
digestive tract. No gross lesions were observed in the kidneys.
Histopathologic examination of the trachea identified loss of cilia,
degeneration and necrosis of epithelial cells, hyperemia and/or
edema in the mucosa and submucosa, and infiltration of heterophils.
Epithelial cell degeneration, necrosis, hyperemia and heterophil,
lymphocyte and macrophage infiltration with edema, and increase in
mucus were also observed in the lung. Hyperemia and inflammatory
lesions as described above including an obstructed lumen of air
capillaries were also seen in para-bronchial tissue. Hyperemia and
granular-vacuolar degeneration were seen in the tubular epithelial
cells of the kidney of some chickens including focal mononuclear
cell infiltration.
TaqMan real-time RT-PCR for AvCoV-IBV. For RT-PCR a CT
value of 35 or less is considered to be positive for the presence of
AvCoV-IBV RNA. AvCoV-IBV RNA was detected in 64.2% (9/14)
of layer flocks and 83.6% (41/49) of broiler flocks.
On further analysis, AvCoV-IBV RNA was detected in 27 out of
30 (90%) tracheal samples, 31 out of 49 (62.2%) lung samples, 7
out of 22 (31.8%) caecal tonsils, and 4 out of 49 (8.1%) kidney
samples. Clinical signs and severe pathologic lesions (gross) were
observed in the organs of birds that scored a CT value of less than 25.
No CT values were obtained from AvCoV-IBV RNA-negative test
samples or negative controls.
Virus isolation. AvCoV-IBV was isolated from tracheal tissues
collected from six broiler flocks and from tracheal swabs taken from
one layer flock after 7 days of incubation after one passage in
embryonated SPF hens’ eggs (Table 1). No AvCoV-IBV detection
was achieved after second or third passages of the other samples
cultured. Dwarfing and hemorrhage of the embryo was observed in
eggs inoculated with AvCoV-IBV RT-PCR-positive inoculum. No
lesions were observed in the control eggs.
Analysis of the partial IBV S1 sequences. Analysis of the partial S1
sequences derived from some of the broiler samples identified that
17.2% of the sequences were closely related (95.6%–99.2%) to the
S1 sequences of IBV Ma5 and 5/49 H120 vaccine strains (GI-1),
and 24/49 (48.9%) of those were similar (94.8%–99.4%) to the
Israel variant-2 (GI-23) (Table 1; Fig. 1). In contrast, all of the
partial S1 sequences obtained from the layer flock samples were
found to be identical to the IBV 4/91 vaccine strain (GI-13) (Table
1; Fig. 1).
The partial S1 sequences of the AvCoV-IBVs detected in five of
the broiler flocks were similar to AvCoV-IBV strains, Ma5, M41
(AY561711), and H120 (FJ888351) (Fig. 1). In addition, the partial
S1 sequences of the AvCoV-IBVs detected in 24 of the broiler flocks
were similar to IBV Israel variant-2 (EU780077, JX027070, and
JX173488) (Fig. 1) and an AvCoV-IBV previously identified and
reported in Turkey (HM802259). Additionally, the Israeli variant-2
detected in this study clustered phylogenetically with the Turkish
IBV strain, chicken/Turkey/10RS-3161/2010, but aligned in a
different subcluster. The partial S1 sequences of AvCoV-IBVs
detected in seven of the layer flocks were different from those found
in broiler flocks but more similar to AvCoV-IBV strains previously
reported from Iran, India, and China. However, they showed some
similarity to Israel variant-1 and 4/91 strains of IBV (Fig. 1).
The AvCoV-IBV identified in this study as having a partial S1
sequence to that of IBV Israel variant-2 also showed similarity to
AvCoV-IBVs Egypt/Beni-Suef/01 (97.8%–99.4%), IS/1494/06
(98.7%–99.7%), IB variant-2 (94.8%–96.7%), and chicken/Tur-
key/10RS-3161/2010 (96.2%–98.1) but with different isolates IS/
885/00 (80.1%–90.1%), IS/ 720/99 (79.3%–88.9%), Sul/01/09
(79.6%–87.8%), and CK/CH/LDL/97I (78.6-83.0%); the last two
have been detected in the Middle East.
Analysis of the partial S1 sequences of AvCoV-IBVs detected in
seven of the layer flocks examined were found to be similar to IBV 4/
91 using the in-house designed primers (IBV-FOR3 and IBV-
REV3; Table 1). The sequences of five of the samples were also
amplified and confirmed using other primers (29).
DISCUSSION
Variants of AvCoV-IBV have been detected in different countries
and are having an economic impact on poultry production globally
(7). Antigenic variation, resulting in decreased level of cross-
protection between different strains, is a major obstacle for the
development of an efficacious vaccine. In this study, the AvCoV IBV
was detected in 83.6% and 64.2% of the broiler and layer flocks
assessed, respectively. Amongst the IBV strains identified in the
broiler flocks, 17.2% represented the detection of the IBV Ma5 and
H120 vaccine strains (95.6%–99.2%) and 48.9% represented the
Israel variant 2 isolate (94.8%–99.4%), whereas all of the layer
flock–derived sequences were represented in the 4/91 vaccine strain
(96.2%–99.5%). Results from field surveys for assessing the presence
of IBV in chickens in Western Europe showed 59% positive for
AvCoV-IBV with about 50% of the positive samples representing
identification of vaccine strains (29). Similarly, vaccine strains were
also detected following the assessment of poultry in the Middle East
for the presence of IBV (13,19,25). Furthermore, in this study, IBV
Israel variant-2 in addition to vaccine strains H120, Ma5, and 4/91
was detected in some flocks that had been vaccinated. Overall these
results demonstrate the existence of different genotypes of IBV
affecting poultry, and in Turkey, in particular, it suggests the
copersistence of IBV vaccine as well as field isolates in poultry flocks,
which could favor the emergence of new virulent virus variants and
escape mutants.
The phylogenetic comparison of the partial S1 sequences derived
from some of the samples in this study showed that 24 of the
sequences from broiler flocks were closely related to IBV Israel
variant-2 isolates, IS/1494/06, IB VAR2, chicken/Turkey/10RS-
3161/2010, and Egypt/Beni-Suef/01, but different from IBV
vaccine strains, H120, Ma5, and 4/91, currently applied to poultry
flocks in Turkey. The sequences identified in this study were also
different from IBV QX and Italy-02 isolates found in other
European countries. In addition, five sequences were found to be
similar to Ma5, H120, and M41, whereas seven sequences were
similar to the 4/91 vaccine strain. The Israeli variant-2 detected in
this study was found to be similar to strain chicken/Turkey/10RS-
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Fig. 1. Maximum likelihood phylogenetic tree of the S1 nucleotide sequences. Viruses sequenced in this study are colored in red. SH-like branch
supports are shown for key nodes.
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3161/2010, previously reported in Turkey; although these isolates
clustered in the same clade, they aligned in a different subcluster.
This observation suggests that the Israeli variant-2 circulating in
Turkey is diverging. In Turkey, chickens are routinely vaccinated
with multiple IBV vaccines, representing heterogeneous serotypes,
including the recent introduction of the vaccine strains 4/91 and
Israel variant-2 to control virulent IBV in poultry. The presence of
these recently introduced vaccine strains were identified by samples
taken from poultry flocks as part of this study.
Turkey has a large and increasing poultry production industry and
serves as a bridge between Europe and Asia with eight neighboring
poultry-producing countries (1,3,19,23,25). The AvCoV-IBV
isolates detected in this study were found to be similar to IBV
isolates detected in Israel, Turkey, Iraq, Jordan, and Egypt like
strains KF179074, HM802259, EU780077, JX027070, JX173488,
and KF153245, but different from IBV isolates QX and Italy-02
(EU780077) (1,15,23,29), detected in other European countries.
The predominance of IBV genotypes representing isolates belonging
to Asian-type lineages, found in this study, suggests that Turkey has
more cross-border poultry trade with Middle Eastern countries than
with European countries.
The pathologic lesions associated with AvCoV-IBVs in Turkey
have not been investigated previously. The predominant histopath-
ologic and necropsy findings observed in this study included
hemorrhages and congestions in the trachea and congestion of the
lungs, which are consistent with previous findings reported from the
field (27) and from experimental infections (2). Kidneys were
affected only in a few birds that were not vaccinated and were
positive for Israeli variant-2. QX-like AvCoV-IBVs as well as strains
found in Israel and northern Iraq are known to induce or be
associated with kidney disease (2,18,19); our results, from both
clinical and sequence analysis, suggests that these types of IBVs are
rarely present in Turkish poultry flocks.
It should be noted that the flocks investigated in this study were
reportedly vaccinated against IBV. Interestingly, mild respiratory
signs were seen in some vaccinated flocks. The detection of AvCoV-
IBV–associated disease in these flocks suggests that either 1) the
current IBV vaccines are not efficacious for protection against some
of the circulating strains identified in this study; 2) the vaccination
regimen applied was inadequate to provide protection; or 3)
chickens are exposed to other respiratory pathogens by stress during
vaccination, which decreases immunity. These speculations need to
be determined in future studies.
In conclusion, AvCoV-IBVs similar to those circulating in various
countries in the Middle East were identified in chickens from
Turkish broiler and layer flocks. Pathologic changes were mainly
detected in the respiratory tract of infected chickens. The results
indicate that Israeli variant-2 circulating in Turkey is undergoing
evolution. The efficacy of the vaccines currently used in Turkey
against some of the circulating AvCoV-IBVs should be assessed in
future studies.
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